Human care company Elekta AB (STO:EKTAB.ST) on Friday announced that the Odette Cancer Centre at Sunnybrook Health Sciences Centre, Totonto, has treated its first patient using Elekta Unity on 15 August 2019.
Reportedly, the patient is receiving treatment for a glioblastoma brain tumour.
According to the company, Elekta Unity is a transformative magnetic resonance radiation therapy (MR/RT) system that enables personalised precision radiation therapy. Elekta Unity combines a state-of-the-art 1.5T MRI scanner, a best-in-class 7 MV linear accelerator and breakthrough real-time adaptive radiotherapy software.
The combination of these technologies allows the radiation dose to be reshaped based on daily changes in shape, size and position of the tumour and surrounding healthy anatomy, as visualized with MRI and then enables accurate dose delivery with real-time visualisation of the tumour.
Elekta Unity had received clearance from the Canadian Nuclear Safety Commission just a few weeks ago.
Elekta Unity has CE-mark and 510(k) clearance and is not commercially available in all markets.
Elekta is a leader in precision radiation medicine.
Norgine submits first marketing authorisation application submissions for approval of eflornithine
Innovent Biologics names new Oncology CMO
UroGen's UGN-103 IND accepted by FDA for bladder cancer treatment
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients
Portage Biotech expands evaluation of strategic alternatives
Stamford Pharmaceuticals starts locally advanced basal cell carcinoma (laBCC) trial of SP-002
QST selects RayStation for advanced carbon ion therapy
Candel Therapeutics granted FDA Orphan Drug Designation for CAN-2409 in pancreatic cancer treatment
Innate Pharma reports preclinical efficacy of IPH45
Roche attains CE Mark for first companion diagnostic for HER2-low metastatic breast cancer
BioCity Biopharma's BC2027 Phase one study IND application receives US FDA approval
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
CLS secures second order from NIH Clinical Center for Thermal Therapy System accessories